Cancer Research Nottingham

Breast Cancer

The links below provide further information on each researcher and their work. 

  • Nottingham Breast Institute
  • Cancer Autoimmunity (CEAC)
Dr Cinzia Allegrucci
Cancer epigenetics; cancer stem cells; cancer reprogramming 
Prof Ian Ellis Breast tumour biomarkers; Nottingham Prognostic Index  
Prof John Robertson Immune biomarkers; early detection; lung and breast tumours
Dr Anna Grabowska Pre-clinical cancer modelling/imaging; target validation; tumour microenvironment
Dr Andrew Green Breast cancer; molecular pathology; tissue microarrays; immunohistochemistry; prognosis  
Dr Stewart Martin
Prognostic and predictive biomarkers; lymphatic biology and metastasis; radiation biology/radiotherapy; calpains and calpastatin  
DNA repair; base excision repair; APE1 inhibitors; stratified medicine;
cancer biomarkers  
Dr Lodewijk Dekker
Annexins; anti-tumour agents; POT1 kinase; telomerase inhibitors 
Dr Nigel Mongan     Androgen receptor; Estrogen receptor; REX1/ZFP42; cancer stem cells; prostate cancer   
Dr Steve Chan       Clinical oncology  
Dr Caroline Chapman Immune biomarkers; B-cells; stem cells; tumour associated antigens
Dr Emad Rahka Breast cancer: molecular pathology, classification and outcome
Dr Nicole Clarke
Tumour suppressor IRF1 function; IRF target genes
Prof David Heery    Histone acetyltransferases; chromatin modification; Nuclear Receptors; BCL11A; PRAME  
Dr Rajendra Kumari Pre-clinical cancer modelling; bioimaging; tumour microenvironment; targeted therapies